Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03725696 · ClinicalTrials.gov registry record
The Effect of Bariatric Surgery on Spermatogenesis
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 25
- Enrollment target
NCT03725696: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT03725696 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03725696 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Little is known about the effects of weight loss surgery on male reproductive health. This study will investigate the effect of bariatric surgery on male infertility by evaluating sexual health, blood hormone levels, and semen parameters before and after roux-en-y bariatric surgery.
Primary Outcome
Changes in sperm concentration on semen analysis
Interventions
- DIAGNOSTIC_TEST Semen Analysis
- DIAGNOSTIC_TEST Hormonal panel
- PROCEDURE RYGB Gastric Bypass
- DIAGNOSTIC_TEST IIEF Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2020-12-31 |
Why NCT03725696 stopped before completion
NCT03725696 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Semen Analysis is the first listed.
NCT03725696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03725696 about?
NCT03725696 is a clinical study titled "The Effect of Bariatric Surgery on Spermatogenesis". Little is known about the effects of weight loss surgery on male reproductive health. This study will investigate the effect of bariatric surgery on male infertility by evaluating sexual health, blood hormone levels, and semen parameters before and after roux-en-y bariatric surgery.
What is the current status of trial NCT03725696?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2018-11-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03725696?
The interventions under investigation include: Semen Analysis (DIAGNOSTIC_TEST), Hormonal panel (DIAGNOSTIC_TEST), RYGB Gastric Bypass (PROCEDURE), IIEF Survey (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03725696?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI